Depo-Provera (DP) and generic equivalent (DMPA) – Federman & Sherwood Investigates
Oklahoma City, OK (April 3, 2025) – Federman & Sherwood, a premier boutique class-action litigation law firm with offices in Oklahoma City and Dallas, is announcing its investigation into claims related to the use of Depo-Provera (DP) and its generic equivalent, Depo-Medroxyprogesterone Acetate (DMPA). These medications are commonly prescribed as injectable birth control and to manage menstrual cycles; at higher doses, they may also be used to treat certain types of cancer. However, emerging evidence suggests that DP and DMPA may be linked to the development of serious brain tumors, including meningiomas.
Depo-Provera Lawsuits Being Pursued
Lawsuits are now being pursued to secure both medical monitoring and financial compensation for women who have been adversely affected by these drugs. If you or someone you know received Depo-Provera or its generic version, you should promptly investigate your legal options.
Federman & Sherwood has built a reputation for aggressive, results-oriented advocacy on behalf of injured parties. With deep experience in pharmaceutical and class-action litigation, the firm is focused on ensuring that individuals harmed by DP or DMPA have access to the compensation and support they need. This includes covering potential medical expenses, lost earnings, pain and suffering, and other relevant damages.
If you believe you have experienced adverse effects from Depo-Provera or its generic equivalent, you are encouraged to contact Federman & Sherwood as soon as possible. By seeking legal counsel, you can learn more about your rights and any potential claims you may have.
About Federman & Sherwood
Federman & Sherwood is a boutique class-action litigation law firm committed to pursuing justice for individuals harmed by corporate negligence and wrongdoing. With offices in Oklahoma City and Dallas, the firm provides comprehensive legal representation rooted in a deep understanding of both state and federal laws. By combining vigorous advocacy with compassionate client service, Federman & Sherwood aims to hold manufacturers accountable and secure fair compensation for victims nationwide.
To learn more or to discuss your potential claims related to Depo-Provera or its generic equivalent, please contact Federman & Sherwood directly.
If you wish to discuss this action, obtain further information, and/or participate in this litigation, please contact Tashia Poore either by email at tdp@federmanlaw.com or visit our firm’s website www.federmanlaw.com.
Tashia Poore
FEDERMAN & SHERWOOD
(405) 235-1560